Free Trial

Alpha Teknova (TKNO) Set to Announce Quarterly Earnings on Monday

Alpha Teknova (NASDAQ:TKNO - Get Free Report) will release its earnings data after the market closes on Monday, May 13th. Parties interested in listening to the company's conference call can do so using this link.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last released its quarterly earnings data on Monday, March 11th. The company reported ($0.22) earnings per share for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. The business had revenue of $7.87 million for the quarter, compared to analysts' expectations of $8.20 million. Alpha Teknova had a negative net margin of 100.26% and a negative return on equity of 38.12%. On average, analysts expect Alpha Teknova to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Alpha Teknova Stock Performance

Alpha Teknova stock traded up $0.08 during midday trading on Monday, reaching $1.98. 8,123 shares of the stock traded hands, compared to its average volume of 14,121. The firm has a fifty day moving average price of $2.50 and a two-hundred day moving average price of $2.74. Alpha Teknova has a fifty-two week low of $1.62 and a fifty-two week high of $4.27. The firm has a market cap of $80.83 million, a price-to-earnings ratio of -1.71 and a beta of 0.39. The company has a current ratio of 5.14, a quick ratio of 3.84 and a debt-to-equity ratio of 0.15.


Wall Street Analysts Forecast Growth

Separately, BTIG Research cut Alpha Teknova from a "buy" rating to a "neutral" rating in a research report on Tuesday, March 12th.

View Our Latest Stock Report on Alpha Teknova

Alpha Teknova Company Profile

(Get Free Report)

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.

Read More

Earnings History for Alpha Teknova (NASDAQ:TKNO)

→ Was the Great Financial Crisis fun? (From Brooks Enterprises) (Ad)

Should you invest $1,000 in Alpha Teknova right now?

Before you consider Alpha Teknova, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alpha Teknova wasn't on the list.

While Alpha Teknova currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Featured Articles and Offers

Search Headlines: